Harman Finochem Limited

Harman Finochem Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24110MH1983PLC029560 Incorporated 17 March 1983 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹1,376.43 Cr
▲ 27% YoY
Net profit · FY 2025
₹207.07 Cr
Net margin 15%
EBITDA · FY 2025
₹400.5 Cr
EBITDA margin 29.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.76 Cr
Issued & subscribed
Open charges
₹1,011.64 Cr
Secured borrowings
Company age
43 yrs
Est. 1983
Employees · EPFO
1,772
Provident fund records

About Harman Finochem Limited

Data last updated:

Harman Finochem Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 March 1983 and has been in existence for over 43 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1983PLC029560. Its GSTIN is 27AABCH3223J1ZS (Maharashtra).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.76 Cr. It was formerly known as Harman Finochem Private Limited and Herman Finochem Private Limited. It is led by directors including Savreen Minhas (Whole-Time Director) and Inderjeet Kaur Bhupinder Singh (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 107 A Vinay Bhavya Complex159 A Cst Rd Kalina Santacruz East, Mumbai, Maharashtra, India – 400098.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,376.43 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹207.07 Cr (net margin 15%) and EBITDA of ₹400.5 Cr (EBITDA margin 29.1%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 16% over five years.

The company has about 1,772 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand: Harman Finochem. As per MCA filings, the company has open charges of ₹1,011.64 Cr on record. Court records list 14 cases involving the company, including 7 filed by the company and 7 filed against it; 1 case is pending. The company has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹3.07 Cr; the latest was in March 2022. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Viyash Life Sciences Private Limited with revenue of ₹1,482.68 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website harmanfinochem.com.

Company Details of Harman Finochem Limited
CIN U24110MH1983PLC029560
Registration Number 029560
Incorporation Date 17 March 1983
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Savreen Minhas Whole-Time Director Inderjeet Kaur Bhupinder Singh Whole-Time Director Gurpreet Singh Minhas Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    harmanfinochem.com
  • Social Media
  • Registered Address
    107 A Vinay Bhavya Complex159 A Cst Rd Kalina Santacruz East, Mumbai, Maharashtra, India – 400098
  • Industry
    Pharma, API Manufacturers
Comprehensive company report
Harman Finochem Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Harman Finochem Limited report

Financials, compliance, directors, charges, ownership and filings for Harman Finochem Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Harman Finochem Limited

The main business activity of Harman Finochem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Harman Finochem Limited FY 2024 filings available

Harman Finochem Limited reported revenue of ₹1,376.43 Cr (up 27% YoY) for FY 2025.

Revenue · FY 2025
₹1,376.43 Cr ▲ 27%
Net profit · FY 2025
₹207.07 Cr margin 15%
EBITDA · FY 2025
₹400.5 Cr margin 29.1%

Compounded Annual Growth Rate (CAGR) of Harman Finochem Limited

Revenue CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 19%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 78%
3 years · compounded
▲ 9%
5 years · compounded
▲ 13%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 27% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Harman Finochem Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹400.5 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹207.07 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Harman Finochem Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin29.1%••••••••••••••••
Net Profit Margin15%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Harman Finochem are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Harman Finochem Limited

Harman Finochem Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Viyash Life Sciences Private Limited₹1,482.68 Cr (FY 2025)••••••••9.0%••••Hyderabad, Telangana, India
Virchow Laboratories Limited₹1,479.64 Cr (FY 2025)••••••••2.0%••••Telangana, India
Teva Api India Private Limited₹1,456.07 Cr (FY 2025)••••••••7.0%••••Mumbai, Maharashtra, India
Dhanuka Laboratories Limited₹1,424.06 Cr (FY 2025)••••••••-3.0%••••Chennai, Tamil Nadu, India
Avaya Industries Limited₹1,397.41 Cr (FY 2019)••••••••19.0%••••Thane, Maharashtra, India
Harman Finochem Limited this company₹1,376.43 Cr (FY 2025)••••••••27.0%••••Mumbai, Maharashtra, India
Cohance Lifesciences Limited₹1,362.25 Cr (FY 2024)••••••••0.0%••••Mumbai, Maharashtra, India
Arch Pharmalabs Limited₹1,344.16 Cr (FY 2023)••••••••2.0%••••Mumbai, Maharashtra, India
Shilpa Medicare Limited Listed₹1,309.57 Cr (FY 2025)••••••••13.0%••••Raichur, Karnataka, India
Solara Active Pharma Sciences Limited Listed₹1,292.08 Cr (FY 2025)••••••••0.0%••••Thane, Maharashtra, India
Vasudha Pharma Chem Limited₹1,174.19 Cr (FY 2025)••••••••1.0%••••Hyderabad, Telangana, India

Peers are the five companies nearest above and the five nearest below Harman Finochem by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Harman Finochem Limited

Harman Finochem Limited is audited by K. U. Kothari & Co. for the financial year 2023.

NameStatusAppointment DateCessation Date
K. U. Kothari & Co.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Harman Finochem Limited

Harman Finochem has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Savreen MinhasWhole-Time Director10 Mar 201412 Years 7 MonthsCurrent
Inderjeet Kaur Bhupinder Singh
Also directs: Well Worth Medicines Private Limited, Kirti Merchantile Private Limited, Shreefal Engineering Private Limited and 1 more
Whole-Time Director11 Feb 199729 Years 8 MonthsCurrent
Gurpreet Singh Minhas
Also directs: Shreefal Engineering Private Limited, Idiscovery Developers Private Limited, Summerset Gardens Resort Private Limited
Whole-Time Director10 Mar 201412 Years 7 MonthsCurrent
Harpreet Singh Bhupinder Singh
Also directs: Well Worth Medicines Private Limited, Kirti Merchantile Private Limited, Shreefal Engineering Private Limited and 4 more
Whole-Time Director11 Feb 199729 Years 8 MonthsCurrent
Manprrit MinhasWhole-Time Director21 May 20251 Years 4 MonthsCurrent
View all directors

Ownership and Shareholding of Harman Finochem Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Harman Finochem Limited

Open charges
₹1,011.64 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹426.67 Cr
Others₹387.64 Cr
Citi Bank N.A.₹180.00 Cr
Indian Bank₹10.00 Cr
Axis Bank Limited₹7.33 Cr
Latest charge details
DateLenderAmountStatus
31 Oct 2025Hdfc Bank Limited₹125 CrOpen
23 Sep 2024Others₹301.64 CrOpen
18 Jun 2024Hdfc Bank Limited₹300 CrOpen
24 Jun 2023Axis Bank Limited₹3 CrOpen
31 Mar 2023Axis Bank Limited₹1.22 CrOpen

Total charge records: 11 View all charges

Deals & Funding of Harman Finochem Limited

Harman Finochem Limited has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹3.07 Cr; the latest was in March 2022.

Total deals
8
Secondary share transfers
6
Funding rounds
2
Disclosed funding
₹3.07 Cr

Deals on record (5 of 8)

WhenDealAmountParties
Mar 2022Secondary share transferUndisclosedBuyer: 3 individuals
Seller: 2 individuals
Nov 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jan 2016Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2014Secondary share transferUndisclosedBuyer: an individual
Seller: Well Worth Medicines Private Limited
Mar 2007Funding round₹2.9 CrInvestors: Kirti Mercantile Pvt.Ltd.
Premium access

Full deal history

All 8 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Associated Brands with Harman Finochem Limited

Harman Finochem operates one associated brand: Harman Finochem. Each brand links to its own profile.

BrandDescriptionWebsite
Harman Finochem
Manufacturing and exporting of active pharmaceutical ingredients in India.harmanfinochem.com

Employees and EPFO Compliance at Harman Finochem Limited

Harman Finochem Limited has a workforce of 1,772 employees as of Apr 09, 2024.

Employee count
1,772
Active EPFO establishments
1
Employee growth
16.27%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Harman Finochem Limited

Harman Finochem has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

2
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company NameCINShares Held
Shreefal Engineering Private LimitedU29252MH2010PTC204950Locked
Idiscovery Developers Private LimitedU45203MH2022PTC376582Locked

Showing major subsidiaries. Total: 2.

Name History of Harman Finochem Limited

Harman Finochem has undergone 2 name changes throughout its history. The company was previously known as Harman Finochem Private Limited, and Herman Finochem Private Limited. The current legal name is Harman Finochem Limited.

Company NameStatus
Harman Finochem LimitedCurrent
Harman Finochem Private LimitedPrevious
Herman Finochem Private LimitedPrevious

CIN History of Harman Finochem Limited

Harman Finochem has one previous CIN (Corporate Identification Number): L24110MH1983PLC029560. The current CIN is U24110MH1983PLC029560, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24110MH1983PLC029560Current
L24110MH1983PLC029560Previous

Recent Activity on Harman Finochem Limited

Harman Finochem Limited has 11 board changes on record since 1997: 5 appointments and 6 cessations. The latest: Manprrit Minhas ceased to be Additional Director on 29 Oct 2025.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 125.00 Cr with Charge ID 101188888 was registered on 31 Oct 2025.
Ceased
Manprrit Minhas ceased to be Additional Director.
Appointed
Manprrit Minhas was appointed as Whole-Time Director.
Charges
A charge with Citi Bank N.A. of Rs. 78.00 Cr registered on 16 Jun 2020 with Charge ID 100358515 was modified on 07 Apr 2025.
Charges
A charge with Indian Bank of Rs. 10.00 Cr registered on 21 Jan 1992 with Charge ID 90239691 was modified on 31 Jan 2025.
AGM
Harman Finochem Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 301.64 Cr with Charge ID 100985626 was registered on 23 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 300.00 Cr with Charge ID 100946938 was registered on 18 Jun 2024.
Filing
Harman Finochem Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Bhupinder Singh Jagdevsingh Manhas ceased to be Managing Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 3.00 Cr with Charge ID 100740973 was registered on 24 Jun 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.22 Cr with Charge ID 100699887 was registered on 31 Mar 2023.

17 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Harman Finochem Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Harman Finochem Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Harman Finochem Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Harman Finochem Limited

Harman Finochem has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCH3223J1ZSMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Harman Finochem Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harman Finochem Limited

Harman Finochem is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 17 March 1983 (43+ years old) and is registered under CIN U24110MH1983PLC029560.

Harman Finochem reported revenue of ₹1,376.43 Cr for FY 2025 (up 27% YoY).

Harman Finochem has 5 current directors:

Harman Finochem reported a net profit of ₹207.07 Cr (net margin 15%) and EBITDA of ₹400.5 Cr (EBITDA margin 29.1%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Harman Finochem is 19% over three years and 16% over five years. In the latest year (FY 2025) revenue rose 27%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Harman Finochem is 27AABCH3223J1ZS, registered in Maharashtra.

The CIN (Corporate Identification Number) of Harman Finochem is U24110MH1983PLC029560. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Harman Finochem has 14 court cases on record: 7 filed by the company and 7 filed against it. 1 is pending. Most are in the high courts.

Harman Finochem was incorporated on 17 March 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.

Harman Finochem has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹3.07 Cr; the latest was in March 2022.

The peers of Harman Finochem by revenue are Viyash Life Sciences Private Limited, Virchow Laboratories Limited, Teva Api India Private Limited, Dhanuka Laboratories Limited, Avaya Industries Limited and 5 more, all in the Pharma industry (API Manufacturers).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available